Bates, G. P. et al. Huntington disease. Nat. Rev. Dis. Primers1, 15005 (2015).

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntingtons-disease chromosomes - Macdonald, M. E. (Cell, 1993)

Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice - Mangiarini, L. (Cell, 1996)

Conditional targeting of medium spiny neurons in the striatal matrix - Reinius, B. (Front Behav. Neurosci., 2015)

The mechanism of degeneration of striatal neuronal subtypes in Huntington disease - Rikani, A. A. (Ann. Neurosci., 2014)

Dysregulation of corticostriatal connectivity in Huntington’s disease: a role for dopamine modulation - Rangel-Barajas, C.; Rebec, G. V. (J. Huntingt. Dis., 2016)

Choosing an animal model for the study of Huntington’s disease - Pouladi, M. A.; Morton, A. J.; Hayden, M. R. (Nat. Rev. Neurosci., 2013)

A huntingtin knockin pig model recapitulates features of selective neurodegeneration in Huntington’s disease - Yan, S. (Cell, 2018)

Towards a transgenic model of Huntington’s disease in a non-human primate - Yang, S. H. (Nature, 2008)

Human embryonic stem cell-derived GABA neurons correct locomotion deficits in quinolinic acid-lesioned mice - Ma, L. (Cell Stem Cell, 2012)

A chemical recipe for generation of clinical-grade striatal neurons from hESCs - Wu, M. (Stem Cell Rep., 2018)

Regenerative approaches in Huntington’s disease: from mechanistic insights to therapeutic protocols - Sassone, J.; Papadimitriou, E.; Thomaidou, D. (Front. Neurosci., 2018)

AAV5-miHTT gene therapy demonstrates suppression of mutant huntingtin aggregation and neuronal dysfunction in a rat model of Huntington’s disease - Miniarikova, J. (Gene Ther., 2017)

Sustained therapeutic reversal of Huntington’s disease by transient repression of huntingtin synthesis - Kordasiewicz, H. B. (Neuron, 2012)

CRISPR/Cas9-mediated gene editing ameliorates neurotoxicity in mouse model of Huntington’s disease - Yang, S. (J. Clin. Investig., 2017)

Tetrabenazine treatment patterns and outcomes for chorea associated with Huntington disease: a retrospective chart review - Claassen, D. O. (J. Huntingt. Dis., 2018)

In vivo reprogramming of striatal NG2 glia into functional neurons that integrate into local host circuitry - Torper, O. (Cell Rep., 2015)

In vivo direct reprogramming of reactive glial cells into functional neurons after brain injury and in an Alzheimer’s disease model - Guo, Z. Y. (Cell Stem Cell, 2014)

Induction of functional dopamine neurons from human astrocytes in vitro and mouse astrocytes in a Parkinson’s disease model - Rivetti di Val Cervo, P. (Nat. Biotechnol., 2017)

In vivo reprogramming of astrocytes to neuroblasts in the adult brain - Niu, W. (Nat. Cell Biol., 2013)

NEUROD1 instructs neuronal conversion in non-reactive astrocytes - Brulet, R. (Stem Cell Rep., 2017)

Ascl1 converts dorsal midbrain astrocytes into functional neurons in vivo - Liu, Y. G. (J. Neurosci., 2015)

Generation of induced neurons via direct conversion in vivo - Torper, O. (Proc. Natl Acad. Sci. USA, 2013)

In vivo reprogramming for CNS repair: regenerating neurons from endogenous glial cells - Li, H. D.; Chen, G. (Neuron, 2016)

New approaches for brain repair-from rescue to reprogramming - Barker, R. A.; Gotz, M.; Parmar, M. (Nature, 2018)

In vivo cellular reprogramming: the next generation - Srivastava, D.; DeWitt, N. (Cell, 2016)

Direct reprogramming of resident NG2 glia into neurons with properties of fast-spiking parvalbumin-containing interneurons - Pereira, M. (Stem Cell Rep., 2017)

SOX2 reprograms resident astrocytes into neural progenitors in the adult brain - Niu, W. Z. (Stem Cell Rep., 2015)

Long-Jiao Ge, F.-H.Y. et al. In vivo neuroregeneration to treat ischemic stroke in adult non-human primate brains through NeuroD1 AAV-based gene therapy. bioRxivhttps://doi.org/10.1101/816066 (2019).

Generation of human striatal neurons by microRNA-dependent direct conversion of fibroblasts - Victor, M. B. (Neuron, 2014)

Reactive astrocytes: production, function, and therapeutic potential - Liddelow, S. A.; Barres, B. A. (Immunity, 2017)

Selective induction of astrocytic gliosis generates deficits in neuronal inhibition - Ortinski, P. I. (Nat. Neurosci., 2010)

Dlx1&2-dependent expression of Zfhx1b (Sip1, Zeb2) regulates the fate switch between cortical and striatal interneurons - McKinsey, G. L. (Neuron, 2013)

Dlx1 and Dlx2 promote interneuron GABA synthesis, synaptogenesis, and dendritogenesis - Pla, R. (Cereb. Cortex, 2018)

Directing astroglia from the cerebral cortex into subtype specific functional neurons - Heinrich, C. (Plos Biol., 2010)

Generation of pure GABAergic neurons by transcription factor programming - Yang, N. (Nat. Methods, 2017)

Functional diversity of supragranular GABAergic neurons in the barrel cortex - Gentet, L. J. (Front Neural Circuits, 2012)

Physiology and pharmacology of striatal neurons - Kreitzer, A. C. (Annu Rev. Neurosci., 2009)

Striatal direct and indirect pathway output structures are differentially altered in mouse models of Huntington’s disease - Barry, J.; Akopian, G.; Cepeda, C.; Levine, M. S. (J. Neurosci., 2018)

Astrocyte Kir4.1 ion channel deficits contribute to neuronal dysfunction in Huntington’s disease model mice - Tong, X. (Nat. Neurosci., 2014)

Cystathionine gamma-lyase deficiency mediates neurodegeneration in Huntington’s disease - Paul, B. D. (Nature, 2014)

Systematic behavioral evaluation of Huntington’s disease transgenic and knock-in mouse models - Menalled, L. (Neurobiol. Dis., 2009)

Therapeutic effects of stem cells in rodent models of Huntington’s disease: Review and electrophysiological findings - Holley, S. M. (CNS Neurosci. Ther., 2018)

Human neural stem cell transplantation rescues functional deficits in R6/2 and Q140 Huntington’s disease mice - Reidling, J. C. (Stem Cell Rep., 2018)

Stem and progenitor cell-based therapy of the central nervous system: hopes, hype, and wishful thinking - Goldman, S. A. (Cell Stem Cell, 2016)

Diverse reprogramming codes for neuronal identity - Tsunemoto, R. (Nature, 2018)

Direct conversion of fibroblasts to functional neurons by defined factors - Vierbuchen, T. (Nature, 2010)

Induced neuronal cells: how to make and define a neuron - Yang, N.; Ng, Y. H.; Pang, Z. P.; Sudhof, T. C.; Wernig, M. (Cell Stem Cell, 2011)

hPSC-derived striatal cells generated using a scalable 3D hydrogel promote recovery in a Huntington disease mouse model - Adil, M. M. (Stem Cell Rep., 2018)

Inhibitory interneuron deficit links altered network activity and cognitive dysfunction in Alzheimer model - Verret, L. (Cell, 2012)

Motor and behavioral phenotype in conditional mutants with targeted ablation of cortical D1 dopamine receptor-expressing cells - Jiang, L. N. (Neurobiol. Dis., 2015)